Approval · Notice of Compliance 14102 · 2013
PREGABALIN: Notice of Compliance 14102
Issued February 14, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14102
- Date
- February 14, 2013
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Analgesic agent
- Canadian reference product
- LYRICA (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREGABALIN | 02396483 | Marketed |
| PREGABALIN | 02396505 | Marketed |
| PREGABALIN | 02396513 | Marketed |
| PREGABALIN | 02396521 | Marketed |
| PREGABALIN | 02396548 | Marketed |
Medicinal ingredients
- PREGABALIN 25 MG per TAB
- PREGABALIN 50 MG per CAP
- PREGABALIN 75 MG per CAP
- PREGABALIN 150 MG per CAP
- PREGABALIN 300 MG per CAP